News

Why a new opioid alternative is out of reach for some pain patients
Journavx is the first truly new painkiller approved by the Food and Drug Administration in more than 20 years. But the drug is expensive, and many people can't get it yet.
Opinion
Why it’s easier to be prescribed an opioid painkiller than the treatment for opioid addiction
Prescription opioid abuse and its downstream effects have reached epidemic proportions in the United States. On May 26, the Food and Drug Administration (FDA) moved a step closer to providing help to ...
The Fourth Wave: How Speedballing Is Creating a New Kind of Drug Crisis
A new approach is urgently needed to address the prevention and treatment of speedballing, the risky—and often ...
Psychology Today6d
Highest Drug-Taking Risks
Polysubstance abuse, using multiple types of drugs at the same time, is a common cause of death from overdose and an ...
A volatile supply: how organizations are responding to constantly evolving street drugs
The unregulated drug supply is now composed of more and more ingredients, making it more difficult to respond, treat and ...
Knowridge Science Report1d
FDA-approved drug can reduce post-surgery pain without heavy opioid use
Researchers at the Medical University of South Carolina have made a breakthrough in pain management. They’ve found that ...